
Stock Story: Intuitive (ISRG US)
Intuitive – the pioneer of robotic assisted minimally invasive surgery
Intuitive (ISRG US) is the global leader in robotic assisted minimally
Intuitive – the pioneer of robotic assisted minimally invasive surgery
Intuitive (ISRG US) is the global leader in robotic assisted minimally
Investment Analyst Roland Houghton explains the opportunity we saw investing in Telstra, Australia’s largest telecommunications business.
What does EBOS do?
EBOS listed on the NZX back in 1960 as a small player in the New Zealand healthcare
Sydney Airport (SYD) has recently become an acquisition target by a consortium of private investors willing to take a longer-term
Value opportunity in a UK bank
Virgin Money UK is a United Kingdom bank offering a classical value investment opportunity that
The a2 Milk Company, or a2, was once a market darling of the NZX. At the end of 2019, the
Amazon is an impressive company. It is a major player in two long term global growth themes, online shopping, and
Blood Plasma is big business. Collecting, processing, manufacturing and ultimately selling plasma derived products has been a valuable area for
Market volatility creates significant opportunities for active investors like Milford, who invest in specific companies rather than simply investing in
It is hard to believe just 3 months have passed since the market lows of late-March. Equity markets have moved
It’s hard to believe what has happened in the last few months: the declaration of a global pandemic, an oil
Quick Links
Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the responsible entity for the Milford Investment Funds. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).
The information provided in this website is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Fund, you should consider the current product disclosure statement (PDS) and Target Market Determination (‘TMD’) of the Fund and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.
Subscribe to weekly insights from our investment experts